In the meantime, we have screened 44 small molecule compounds from the most recent review literature on monoamine transporter protein drugs . All of these compounds are selective serotonin reuptake inhibitors (SSRIs) either on the market or under clinical investigation. To meet the training needs of the CNSMolGen model, we removed the stereochemical information of these compounds and finalized 36 compounds as the fine-tuned training dataset.